Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients
- PMID: 16721778
- DOI: 10.1002/lt.20749
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients
Comment on
-
Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.Liver Transpl. 2006 Jan;12(1):112-6. doi: 10.1002/lt.20562. Liver Transpl. 2006. PMID: 16382458
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
